[1] Ali R, Rakha E A, Madhusudan S et al. DNA damage repair in breast cancer and its therapeutic implications[J]. Pathology, 49, 156-165(2017). http://www.ncbi.nlm.nih.gov/pubmed/28034453

[2] Xu X Y, Wang Q, Xu P et al. Expression of ERCC1 and BRCA1 in tissues of advanced non-small-cell lung cancer and its relationship with the sensitivity of platinum based chemotherapy[J]. Chinese Journal of Cancer Prevention & Treatment, 24, 178-182(2017).

[3] Anantha R W, Simhadri S, Foo T K et al. Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance[J]. eLife, 6, e21350(2017). http://pubmedcentralcanada.ca/pmcc/articles/PMC5432210/

[4] O'Grady S. Finn S P, Cuffe S, et al. The role of DNA repair pathways in cisplatin resistant lung cancer[J]. Cancer Treatment Reviews, 40, 1161-1170(2014).

[5] Wieringa H W, van der Zee A et al. . Breaking the DNA damage response to improve cervical cancer treatment[J]. Cancer Treatment Reviews, 42, 30-40(2016). http://www.ncbi.nlm.nih.gov/pubmed/26643553

[6] Albarakati N. Abdel-Fatah T M A, Doherty R, et al. Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy[J]. Molecular Oncology, 9, 204-217(2015). http://www.ncbi.nlm.nih.gov/pubmed/25205036

[7] Domagala P, Hybiak J, Rys J et al. Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancers[J]. Oncotarget, 7, 68662-68673(2016). http://pubmedcentralcanada.ca/pmcc/articles/PMC5356581/

[8] Shim H J, Yun J J, Bae W K et al. BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin[J]. Cancer Science, 101, 1247-1254(2010). http://labs.europepmc.org/abstract/MED/20331623

[9] Sun C, Li N, Yang Z et al. miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition[J]. Journal of the National Cancer Institute, 105, 1750-1758(2013). http://europepmc.org/abstract/med/24168967

[10] Busschots S. O'Toole S, O'Leary J J, et al. Carboplatin and taxol resistance develops more rapidly in functional BRCA1 compared to dysfunctional BRCA1 ovarian cancer cells[J]. Experimental Cell Research, 336, 1-14(2015). http://www.ncbi.nlm.nih.gov/pubmed/25499884

[11] Bernabeu E, Cagel M, Lagomarsino E et al. Paclitaxel: what has been done and the challenges remain ahead[J]. International Journal of Pharmaceutics, 526, 474-495(2017). http://europepmc.org/abstract/MED/28501439

[12] Promkan M, Liu G, Patmasiriwat P et al. BRCA1 suppresses the expression of survivin and promotes sensitivity to paclitaxel through the calcium sensing receptor (CaSR) in human breast cancer cells[J]. Cell Calcium, 49, 79-88(2011).

[13] Qi S, Yang L, Wen X et al. Reference gene selection for RT-qPCR analysis of flower development in chrysanthemum morifolium and chrysanthemum lavandulifolium[J]. Frontiers in Plant Science, 7, 287(2016). http://pubmedcentralcanada.ca/pmcc/articles/PMC4786574/?report=reader

[14] Rooper L M, Gandhi M, Bishop J A et al. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization[J]. Oral Oncology, 55, 11-16(2016).

[15] Kumar S, Zheng H, Deng B et al. A slot blot immunoassay for quantitative detection of plasmodium falciparum circumsporozoite protein in mosquito midgut oocyst[J]. Plos One, 9, e115807(2014). http://europepmc.org/articles/PMC4274163

[16] Schwarzkopf M, Pierce N A. Multiplexed miRNA northern blots via hybridization chainreaction[J]. Nucleic Acids Research, 44, e129(2016). http://www.ncbi.nlm.nih.gov/pubmed/27270083

[17] Adinolfi B, Pellegrino M, Giannetti A et al. Molecular beacon-decorated polymethylmethacrylate core-shell fluorescent nanoparticles for the detection of survivin mRNA in human cancer cells[J]. Biosensors & Bioelectronics, 88, 15-24(2016). http://europepmc.org/abstract/MED/27321444

[18] Jackson S R, Wong A C, Travis A R et al. Applications of hairpin DNA-functionalized gold nanoparticles for imaging mRNA in living cells[J]. Methods in Enzymology, 572, 87-103(2016). http://www.sciencedirect.com/science/article/pii/S0076687916001312

[19] Zhou Q, Ma Y, Wang Z et al. Optimized ultrasound conditions for enhanced sensitivity of molecular beacons in the detection of MDR1 mRNA in living cells[J]. Analytical Chemistry, 88, 2808-2816(2016). http://pubs.acs.org/doi/abs/10.1021/acs.analchem.5b04503

[20] Deng D, Li Y, Xue J et al. Gold nanoparticle-based beacon to detect STAT5b mRNA expression in living cells: a case optimized by bioinformatics screen[J]. International Journal of Nanomedicine, 10, 3231-3244(2015). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422291/

[21] Kor K, Turner A P, Zarei K et al. Structurally responsive oligonucleotide-based single-probe lateral-flow test for detection of miRNA-21 mimics[J]. Analytical and Bioanalytical Chemistry, 408, 1475-1485(2016). http://link.springer.com/article/10.1007/s00216-015-9250-9

[22] Xue J, Shan L, Chen H et al. Visual detection of STAT5B gene expression in living cell using the hairpin DNA modified gold nanoparticle beacon[J]. Biosensors & Bioelectronics, 41, 71-77(2013). http://www.ncbi.nlm.nih.gov/pubmed/23122230

[23] Li Y, Xue J P, Cui S S et al. Gold nanoparticle-based fluorescent molecular beacon for the detection of STAT5b mRNA expression in living cell[J]. Chinese Science Bulletin, 58, 537-544(2013).

[24] Frens G. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions[J]. Nature, 241, 20-22(1973). http://www.nature.com/nature-physci/journal/v241/n105/abs/physci241020a0.html

[25] Wang M, Hou X, Wiraja C et al. Smart magnetic nanosensors synthesized through layer-by-layer deposition of molecular beacons for non-invasive and longitudinal monitoring of cellular mRNA[J]. ACS Applied Materials & Interfaces, 8, 5877-5886(2016). http://www.ncbi.nlm.nih.gov/pubmed/26878880

[26] Wu X A. Choi C H J, Zhang C, et al. Intracellular fate of spherical nucleic acid nanoparticle conjugates[J]. Journal of the American Chemical Society, 136, 7726-7733(2014).

[27] Zhang J, Zhao Q, Wu Y et al. The construction of a novel nucleic acids detection microplatform based on the NSET for one-step detecting TK1-DNA and microRNA-21[J]. Biosensors & Bioelectronics, 97, 26-33(2017). http://www.ncbi.nlm.nih.gov/pubmed/28549267